{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:20:17Z","timestamp":1792920017957,"version":"4.5.0"},"publisher-location":"New York, NY","reference-count":43,"publisher":"Springer New York","isbn-type":[{"value":"9781493966530","type":"print"},{"value":"9781493966554","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T00:00:00Z","timestamp":1479772800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-6655-4_2","type":"book-chapter","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T01:25:45Z","timestamp":1479777945000},"page":"33-55","source":"Crossref","is-referenced-by-count":42,"title":["Epstein-Barr Virus: Clinical Diagnostics"],"prefix":"10.1007","author":[{"given":"Hans-Helmut","family":"Niller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,22]]},"reference":[{"key":"2_CR1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma. Lancet 1:702\u2013703","journal-title":"Lancet"},{"issue":"5276","key":"2_CR2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/2281056a0","volume":"228","author":"H zur Hausen","year":"1970","unstructured":"zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L (1970) EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228(5276):1056\u20131058","journal-title":"Nature"},{"issue":"138","key":"2_CR3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/newbio244245a0","volume":"244","author":"H Wolf","year":"1973","unstructured":"Wolf H, zur Hausen H, Becker V (1973) EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol 244(138):245\u2013247","journal-title":"Nat New Biol"},{"issue":"7","key":"2_CR4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI (2000) Epstein-Barr virus infection. N Engl J Med 343(7):481\u2013492","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"2_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/10428190802311417","volume":"49","author":"JI Cohen","year":"2008","unstructured":"Cohen JI, Bollard CM, Khanna R, Pittaluga S (2008) Current understanding of the role of Epstein-Barr virus in lymphomagenesis and therapeutic approaches to EBV-associated lymphomas. Leuk Lymphoma 49(Suppl 1):27\u201334","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2_CR6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.semcancer.2009.07.002","volume":"19","author":"GW Bornkamm","year":"2009","unstructured":"Bornkamm GW (2009) Epstein-Barr virus and its role in the pathogenesis of Burkitt\u2019s lymphoma: an unresolved issue. Semin Cancer Biol 19(6):351\u2013365","journal-title":"Semin Cancer Biol"},{"key":"2_CR7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3389\/fgene.2014.00367","volume":"5","author":"HH Niller","year":"2014","unstructured":"Niller HH, Szenthe K, Minarovits J (2014) Epstein-Barr virus-host cell interactions: an epigenetic dialog? Front Genet 5:367","journal-title":"Front Genet"},{"issue":"1","key":"2_CR8","first-page":"HY1","volume":"9","author":"HH Niller","year":"2003","unstructured":"Niller HH, Salamon D, Ilg K, Koroknai A, Banati F, Bauml G, Rucker O, Schwarzmann F, Wolf H, Minarovits J (2003) The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis. Med Sci Monit 9(1):HY1\u2013HY9","journal-title":"Med Sci Monit"},{"issue":"3","key":"2_CR9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.mehy.2003.11.001","volume":"62","author":"HH Niller","year":"2004","unstructured":"Niller HH, Salamon D, Ilg K, Koroknai A, Banati F, Schwarzmann F, Wolf H, Minarovits J (2004) EBV-associated neoplasms: alternative pathogenetic pathways. Med Hypotheses 62(3):387\u2013391","journal-title":"Med Hypotheses"},{"issue":"6","key":"2_CR10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2141.2011.09007.x","volume":"156","author":"S Gromminger","year":"2012","unstructured":"Gromminger S, Mautner J, Bornkamm GW (2012) Burkitt lymphoma: the role of Epstein-Barr virus revisited. Br J Haematol 156(6):719\u2013729","journal-title":"Br J Haematol"},{"key":"2_CR11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.semcancer.2014.04.004","volume":"26","author":"AB Rickinson","year":"2014","unstructured":"Rickinson AB (2014) Co-infections, inflammation and oncogenesis: future directions for EBV research. Semin Cancer Biol 26:99\u2013115","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"2_CR12","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/leu.2013.4","volume":"27","author":"B Kreck","year":"2013","unstructured":"Kreck B, Richter J, Ammerpohl O, Barann M, Esser D, Petersen BS, Vater I, Murga Penas EM, Bormann Chung CA, Seisenberger S, Lee Boyd V, Smallwood S, Drexler HG, Macleod RA, Hummel M, Krueger F, Hasler R, Schreiber S, Rosenstiel P, Franke A, Siebert R (2013) Base-pair resolution DNA methylome of the EBV-positive Endemic Burkitt lymphoma cell line DAUDI determined by SOLiD bisulfite-sequencing. Leukemia 27(8):1751\u20131753","journal-title":"Leukemia"},{"issue":"2","key":"2_CR13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1101\/gr.157743.113","volume":"24","author":"KD Hansen","year":"2014","unstructured":"Hansen KD, Sabunciyan S, Langmead B, Nagy N, Curley R, Klein G, Klein E, Salamon D, Feinberg AP (2014) Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalization. Genome Res 24(2):177\u2013184","journal-title":"Genome Res"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3389\/fmicb.2014.00728","volume":"5","author":"M Navari","year":"2014","unstructured":"Navari M, Fuligni F, Laginestra MA, Etebari M, Ambrosio MR, Sapienza MR, Rossi M, De Falco G, Gibellini D, Tripodo C, Pileri SA, Leoncini L, Piccaluga PP (2014) Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus. Front Microbiol 5:728","journal-title":"Front Microbiol"},{"issue":"11","key":"2_CR15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.tim.2004.09.006","volume":"12","author":"HH Niller","year":"2004","unstructured":"Niller HH, Salamon D, Banati F, Schwarzmann F, Wolf H, Minarovits J (2004) The LCR of EBV makes Burkitt\u2019s lymphoma endemic. Trends Microbiol 12(11):495\u2013499","journal-title":"Trends Microbiol"},{"issue":"3","key":"2_CR16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.semcancer.2009.02.012","volume":"19","author":"HH Niller","year":"2009","unstructured":"Niller HH, Wolf H, Minarovits J (2009) Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia. Semin Cancer Biol 19(3):158\u2013164","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"2_CR17","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1073\/pnas.0810619106","volume":"106","author":"B Gruhne","year":"2009","unstructured":"Gruhne B, Sompallae R, Marescotti D, Kamranvar SA, Gastaldello S, Masucci MG (2009) The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc Natl Acad Sci U S A 106(7):2313\u20132318","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2_CR18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/JVI.05648-11","volume":"86","author":"JY Cao","year":"2012","unstructured":"Cao JY, Mansouri S, Frappier L (2012) Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses. J Virol 86(1):382\u2013394","journal-title":"J Virol"},{"issue":"9","key":"2_CR19","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/v4091537","volume":"4","author":"L Frappier","year":"2012","unstructured":"Frappier L (2012) Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival. Viruses 4(9):1537\u20131547","journal-title":"Viruses"},{"issue":"2","key":"2_CR20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1128\/JCM.28.2.211-215.1990","volume":"28","author":"A Linde","year":"1990","unstructured":"Linde A, Fridell E, Dahl H, Andersson J, Biberfeld P, Wahren B (1990) Effect of primary Epstein-Barr virus infection on human herpesvirus 6, cytomegalovirus, and measles virus immunoglobulin G titers. J Clin Microbiol 28(2):211\u2013215","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2_CR21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/jmv.1890440308","volume":"44","author":"W Karner","year":"1994","unstructured":"Karner W, Bauer G (1994) Activation of a varicella-zoster virus-specific IgA response during acute Epstein-Barr virus infection. J Med Virol 44(3):258\u2013262","journal-title":"J Med Virol"},{"issue":"9","key":"2_CR22","first-page":"586","volume":"33","author":"G Bauer","year":"1992","unstructured":"Bauer G (1992) Die Aussagem\u00f6glichkeiten der Epstein-Barr-Virus-Diagnostik [The diagnostic value of Epstein-Barr virus diagnosis]. Internist (Berl) 33(9):586\u2013592","journal-title":"Internist (Berl)"},{"key":"2_CR23","first-page":"623","volume":"41","author":"G Bauer","year":"1995","unstructured":"Bauer G (1995) Rationale und rationelle EBV-Diagnostik. Clin Lab 41:623\u2013634","journal-title":"Clin Lab"},{"key":"2_CR24","first-page":"296","volume":"2","author":"M Schillinger","year":"1993","unstructured":"Schillinger M, Kampmann M, Henninger K, Murray G, Hanselmann I, Bauer G (1993) Variability of humoral immune response to acute Epstein-Barr virus (EBV) infection: evaluation of the significance of serological markers. Med Microbiol Lett 2:296\u2013303","journal-title":"Med Microbiol Lett"},{"issue":"5\u20136","key":"2_CR25","first-page":"223","volume":"47","author":"G Bauer","year":"2001","unstructured":"Bauer G (2001) Simplicity through complexity: immunoblot with recombinant antigens as the new gold standard in Epstein-Barr virus serology. Clin Lab 47(5\u20136):223\u2013230","journal-title":"Clin Lab"},{"issue":"3","key":"2_CR26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0378-1119(86)90234-9","volume":"42","author":"M Motz","year":"1986","unstructured":"Motz M, Fan J, Seibl R, Jilg W, Wolf H (1986) Expression of the Epstein-Barr virus 138-kDa early protein in Escherichia coli for the use as antigen in diagnostic tests. Gene 42(3):303\u2013312","journal-title":"Gene"},{"issue":"10","key":"2_CR27","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1249\/01.mss.0000230122.91264.3f","volume":"38","author":"T Pottgiesser","year":"2006","unstructured":"Pottgiesser T, Wolfarth B, Schumacher YO, Bauer G (2006) Epstein-Barr virus serostatus: no difference despite aberrant patterns in athletes and control group. Med Sci Sports Exerc 38(10):1782\u20131791","journal-title":"Med Sci Sports Exerc"},{"issue":"9","key":"2_CR28","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/jmv.23253","volume":"84","author":"T Pottgiesser","year":"2012","unstructured":"Pottgiesser T, Schumacher YO, Wolfarth B, Schmidt-Trucksass A, Bauer G (2012) Longitudinal observation of Epstein-Barr virus antibodies in athletes during a competitive season. J Med Virol 84(9):1415\u20131422","journal-title":"J Med Virol"},{"issue":"1","key":"2_CR29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0166-0934(95)01970-7","volume":"57","author":"U Reischl","year":"1996","unstructured":"Reischl U, Gerdes C, Motz M, Wolf H (1996) Expression and purification of an Epstein-Barr virus encoded 23-kDa protein and characterization of its immunological properties. J Virol Methods 57(1):71\u201385","journal-title":"J Virol Methods"},{"key":"2_CR30","first-page":"125","volume":"43","author":"T Wolter","year":"1997","unstructured":"Wolter T, Gassmann C, Vetter V, Bauer G (1997) Avidity determination: utilization of a basic immunological mechanisms allows to improve serological diagnosis of infections. Clin Lab 43:125\u2013135","journal-title":"Clin Lab"},{"issue":"3","key":"2_CR31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/jmv.1890430308","volume":"43","author":"A Andersson","year":"1994","unstructured":"Andersson A, Vetter V, Kreutzer L, Bauer G (1994) Avidities of IgG directed against viral capsid antigen or early antigen: useful markers for significant Epstein-Barr virus serology. J Med Virol 43(3):238\u2013244","journal-title":"J Med Virol"},{"issue":"1","key":"2_CR32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0928-0197(94)90033-7","volume":"2","author":"V Vetter","year":"1994","unstructured":"Vetter V, Kreutzer L, Bauer G (1994) Differentiation of primary from secondary anti-EBNA-1-negative cases by determination of avidity of VCA-IgG. Clin Diagn Virol 2(1):29\u201339","journal-title":"Clin Diagn Virol"},{"issue":"1","key":"2_CR33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0166-0934(95)01971-5","volume":"57","author":"B Weber","year":"1996","unstructured":"Weber B, Brunner M, Preiser W, Doerr HW (1996) Evaluation of 11 enzyme immunoassays for the detection of immunoglobulin M antibodies to Epstein-Barr virus. J Virol Methods 57(1):87\u201393","journal-title":"J Virol Methods"},{"issue":"1","key":"2_CR34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/CDLI.10.1.78-82.2003","volume":"10","author":"BC G\u00e4rtner","year":"2003","unstructured":"G\u00e4rtner BC, Hess RD, Bandt D, Kruse A, Rethwilm A, Roemer K, Mueller-Lantzsch N (2003) Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method. Clin Diagn Lab Immunol 10(1):78\u201382","journal-title":"Clin Diagn Lab Immunol"},{"issue":"5","key":"2_CR35","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1128\/CVI.00104-14","volume":"21","author":"I Corrales","year":"2014","unstructured":"Corrales I, Gimenez E, Navarro D (2014) Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method. Clin Vaccine Immunol 21(5):684\u2013688","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"2_CR36","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1128\/CVI.00754-13","volume":"21","author":"A Guerrero-Ramos","year":"2014","unstructured":"Guerrero-Ramos A, Patel M, Kadakia K, Haque T (2014) Performance of the architect EBV antibody panel for determination of Epstein-Barr virus infection stage in immunocompetent adolescents and young adults with clinical suspicion of infectious mononucleosis. Clin Vaccine Immunol 21(6):817\u2013823","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"2_CR37","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1128\/JCM.38.6.2458-2458.2000","volume":"38","author":"BC G\u00e4rtner","year":"2000","unstructured":"G\u00e4rtner BC, Kortmann K, Schafer M, Mueller-Lantzsch N, Sester U, Kaul H, Pees H (2000) No correlation in Epstein-Barr virus reactivation between serological parameters and viral load. J Clin Microbiol 38(6):2458","journal-title":"J Clin Microbiol"},{"issue":"2","key":"2_CR38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jcv.2010.03.016","volume":"48","author":"B G\u00e4rtner","year":"2010","unstructured":"G\u00e4rtner B, Preiksaitis JK (2010) EBV viral load detection in clinical virology. J Clin Virol 48(2):82\u201390","journal-title":"J Clin Virol"},{"issue":"8","key":"2_CR39","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1158\/1078-0432.CCR-12-2897","volume":"19","author":"M Adham","year":"2013","unstructured":"Adham M, Greijer AE, Verkuijlen SA, Juwana H, Fleig S, Rachmadi L, Malik O, Kurniawan AN, Roezin A, Gondhowiardjo S, Atmakusumah D, Stevens SJ, Hermani B, Tan IB, Middeldorp JM (2013) Epstein-Barr virus DNA load in nasopharyngeal brushings and whole blood in nasopharyngeal carcinoma patients before and after treatment. Clin Cancer Res 19(8):2175\u20132186","journal-title":"Clin Cancer Res"},{"key":"2_CR40","doi-asserted-by":"crossref","unstructured":"Styczynski J, Reusser P, Einsele H, de la Camara R, Cordonnier C, Ward KN, Ljungman P, Engelhard D, Second European Conference on Infections in L (2009) Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia. Bone Marrow Transplant 43(10):757\u2013770","DOI":"10.1038\/bmt.2008.386"},{"issue":"5","key":"2_CR41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/rmv.582","volume":"18","author":"H Kimura","year":"2008","unstructured":"Kimura H, Ito Y, Suzuki R, Nishiyama Y (2008) Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease. Rev Med Virol 18(5):305\u2013319","journal-title":"Rev Med Virol"},{"issue":"5","key":"2_CR42","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1399-3062.2011.00621.x","volume":"13","author":"NA Kittan","year":"2011","unstructured":"Kittan NA, Beier F, Kurz K, Niller HH, Egger L, Jilg W, Andreesen R, Holler E, Hildebrandt GC (2011) Isolated cerebral manifestation of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: a case of clinical and diagnostic challenges. Transpl Infect Dis 13(5):524\u2013530","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"2_CR43","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s15010-007-6354-y","volume":"36","author":"A Plentz","year":"2008","unstructured":"Plentz A, Jilg W, Kochanowski B, Ibach B, Knoll A (2008) Detection of herpesvirus DNA in cerebrospinal fluid and correlation with clinical symptoms. Infection 36(2):158\u2013162","journal-title":"Infection"}],"container-title":["Methods in Molecular Biology","Epstein Barr Virus"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-6655-4_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T12:16:45Z","timestamp":1601209005000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-6655-4_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,22]]},"ISBN":["9781493966530","9781493966554"],"references-count":43,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-6655-4_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,22]]}}}